Net Change In Cash - Devyser Diagnostics AB (STO:DVYSR) - Alpha Spread
D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 117.5 SEK 0.43% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Devyser Diagnostics AB
Net Change in Cash Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Net Change in Cash
-kr100.6m
CAGR 3-Years
-267%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Net Change in Cash
kr55.8m
CAGR 3-Years
-65%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Net Change in Cash
-kr35.5m
CAGR 3-Years
25%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Net Change in Cash
kr165m
CAGR 3-Years
-26%
CAGR 5-Years
46%
CAGR 10-Years
12%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Net Change in Cash
-kr11m
CAGR 3-Years
N/A
CAGR 5-Years
60%
CAGR 10-Years
N/A
BioArctic AB
STO:BIOA B
Net Change in Cash
-kr193.8m
CAGR 3-Years
-20%
CAGR 5-Years
0%
CAGR 10-Years
N/A

See Also

What is Devyser Diagnostics AB's Net Change in Cash?
Net Change in Cash
-100.6m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Net Change in Cash amounts to -100.6m SEK.

What is Devyser Diagnostics AB's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
-267%

Over the last year, the Net Change in Cash growth was -617%. The average annual Net Change in Cash growth rates for Devyser Diagnostics AB have been -267% over the past three years .

Back to Top